• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Treatment decision-making for localized prostate cancer: what younger men choose and why.局限性前列腺癌的治疗决策:年轻男性的选择及原因。
Prostate. 2012 Jan;72(1):58-64. doi: 10.1002/pros.21406. Epub 2011 Apr 25.
2
Choosing active surveillance versus curative treatment in a population-based survey of men with low-risk prostate cancer.在一项基于人群的低危前列腺癌男性调查中,选择主动监测与治愈性治疗。
Ann Fam Med. 2022 Apr 1;20(20 Suppl 1):2917. doi: 10.1370/afm.20.s1.2917.
3
Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.癌症认知和医疗信息不一致与决策冲突相关:一项对接受主动监测的前列腺癌男性的初步研究。
BJU Int. 2012 Jul;110(2 Pt 2):E50-6. doi: 10.1111/j.1464-410X.2011.10791.x. Epub 2011 Dec 7.
4
Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study.局部前列腺癌男性患者的护理满意度:一项全国范围内基于人群的研究。
Eur Urol Oncol. 2018 May;1(1):37-45. doi: 10.1016/j.euo.2018.02.003. Epub 2018 May 15.
5
Decision-Making in Prostate Cancer – Choosing Active Surveillance Over Other Treatment Options: A Literature Review.前列腺癌的决策——选择主动监测而非其他治疗方案:一项文献综述
Urol Nurs. 2017 Jan-Feb;37(1):15-22.
6
Decision-making processes among men with low-risk prostate cancer: A survey study.低危前列腺癌男性的决策过程:一项调查研究。
Psychooncology. 2018 Jan;27(1):325-332. doi: 10.1002/pon.4469. Epub 2017 Jul 13.
7
Factors Affecting Satisfaction with the Decision-Making Process and Decision Regret for Men with a New Diagnosis of Prostate Cancer.影响前列腺癌新诊断男性对决策过程满意度和决策后悔的因素。
Am J Mens Health. 2021 Jul-Aug;15(4):15579883211026812. doi: 10.1177/15579883211026812.
8
Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey.为何患者会选择前列腺切除术或近距离放射疗法来治疗局限性前列腺癌:一项描述性调查的结果
Urology. 2003 Feb;61(2):402-7. doi: 10.1016/s0090-4295(02)02162-3.
9
Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance.影响主动监测前列腺癌患者治疗决策和信息偏好的因素。
Patient Educ Couns. 2012 Jun;87(3):369-74. doi: 10.1016/j.pec.2011.11.009. Epub 2011 Dec 15.
10
Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.低风险前列腺癌男性对主动监测与积极治疗的治疗偏好
Cancer Epidemiol Biomarkers Prev. 2016 Aug;25(8):1240-50. doi: 10.1158/1055-9965.EPI-15-1079. Epub 2016 Jun 2.

引用本文的文献

1
Key Determinants Influencing Treatment Decision-Making for and Adherence to Active Surveillance for Prostate Cancer: A Systematic Review.影响前列腺癌积极监测治疗决策和依从性的关键决定因素:一项系统综述。
J Pers Med. 2025 Jul 15;15(7):315. doi: 10.3390/jpm15070315.
2
Men's experiences of decision-making in life-prolonging treatments of metastatic castration-resistant prostate cancer - wishing for a process adapted to personal preferences: a prospective interview study.转移性去势抵抗性前列腺癌延长生命治疗中男性的决策经历——期望有一个适应个人偏好的过程:一项前瞻性访谈研究
BMC Med Inform Decis Mak. 2025 Mar 31;25(1):153. doi: 10.1186/s12911-025-02985-x.
3
Qualitative study to explore reasons for 'no-show' after diagnosis of breast cancer in a private teaching hospital in Kerala.一项定性研究,旨在探究喀拉拉邦一家私立教学医院中乳腺癌确诊后患者“未就诊”的原因。
J Family Med Prim Care. 2025 Feb;14(2):609-616. doi: 10.4103/jfmpc.jfmpc_142_24. Epub 2025 Feb 21.
4
Recasting the gold standard - part II of II: communicating healthcare options along a continuum of care.重塑金标准——第二部分:沿着护理连续体沟通医疗保健选择。
J Feline Med Surg. 2023 Dec;25(12):1098612X231215639. doi: 10.1177/1098612X231215639.
5
Association of race/ethnicity and patient care experiences with receipt of definitive treatment among prostate cancer survivors: a SEER-CAHPS study.种族/民族和患者护理体验与前列腺癌幸存者接受确定性治疗之间的关联:一项 SEER-CAHPS 研究。
Cancer Causes Control. 2024 Apr;35(4):647-659. doi: 10.1007/s10552-023-01834-4. Epub 2023 Nov 25.
6
Prevalence and determinants of decision regret in long-term prostate cancer survivors following radical prostatectomy.根治性前列腺切除术治疗后长期前列腺癌幸存者决策后悔的发生率及决定因素。
BMC Urol. 2023 Aug 23;23(1):139. doi: 10.1186/s12894-023-01311-9.
7
Rural-Urban Disparities in Patient Care Experiences among Prostate Cancer Survivors: A SEER-CAHPS Study.前列腺癌幸存者就医体验中的城乡差异:一项监测、流行病学和最终结果-医疗保健消费者评估调查(SEER-CAHPS)研究
Cancers (Basel). 2023 Mar 23;15(7):1939. doi: 10.3390/cancers15071939.
8
Patient participation in treatment decision-making of prostate cancer: a qualitative study.患者参与前列腺癌治疗决策:一项定性研究。
Support Care Cancer. 2022 May;30(5):4189-4200. doi: 10.1007/s00520-021-06753-1. Epub 2022 Jan 27.
9
Preparing Patients with Early Stage Prostate Cancer to Participate in Clinical Appointments Using a Shared Decision Making Training Video.使用共享决策制定培训视频准备早期前列腺癌患者参加临床预约。
Med Decis Making. 2022 Apr;42(3):364-374. doi: 10.1177/0272989X211028563. Epub 2021 Oct 7.
10
Patient Participation in Communication about Treatment Decision-Making for Localized Prostate Cancer during Consultation Visits.患者在门诊就诊期间参与局限性前列腺癌治疗决策沟通的情况。
Health N Hav. 2015 Nov;7(11):1419-1429. doi: 10.4236/health.2015.711156. Epub 2015 Nov 11.

本文引用的文献

1
Access to information sources and treatment considerations among men with local stage prostate cancer.局限性前列腺癌男性获取信息来源及治疗考量
Urology. 2009 Sep;74(3):509-15. doi: 10.1016/j.urology.2009.01.090. Epub 2009 Jul 9.
2
Predictors of affect following treatment decision-making for prostate cancer: conversations, cognitive processing, and coping.前列腺癌治疗决策后情感的预测因素:对话、认知加工与应对
Psychooncology. 2009 May;18(5):508-14. doi: 10.1002/pon.1420.
3
Information seeking and satisfaction with physician-patient communication among prostate cancer survivors.前列腺癌幸存者的信息寻求与对医患沟通的满意度
Health Commun. 2008;23(1):62-9. doi: 10.1080/10410230701806982.
4
Factors that predict treatment choice and satisfaction with the decision in men with localized prostate cancer.预测局限性前列腺癌男性治疗选择及对治疗决策满意度的因素。
Clin Genitourin Cancer. 2006 Dec;5(3):219-26. doi: 10.3816/CGC.2006.n.040.
5
Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer.男性为何选择一种治疗方法而非另一种?:局部前列腺癌患者决策过程的综述
Cancer. 2006 May 1;106(9):1865-74. doi: 10.1002/cncr.21822.
6
Patient-focussed decision-making in early-stage prostate cancer: insights from a cognitively based decision aid.早期前列腺癌以患者为中心的决策制定:基于认知的决策辅助工具的见解
Health Expect. 2004 Jun;7(2):126-41. doi: 10.1111/j.1369-7625.2004.00271.x.
7
Evidence of increased prostate cancer detection in men aged 50 to 59: a review of 324,684 biopsies performed between 1995 and 2002.50至59岁男性前列腺癌检测率上升的证据:对1995年至2002年间进行的324,684例活检的回顾。
Urology. 2003 Dec;62(6):1045-9. doi: 10.1016/s0090-4295(03)00782-9.
8
Treatment decision-making by men with localized prostate cancer: the influence of personal factors.局限性前列腺癌男性的治疗决策:个人因素的影响
Urol Oncol. 2003 Mar-Apr;21(2):93-100. doi: 10.1016/s1078-1439(02)00209-0.
9
Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey.为何患者会选择前列腺切除术或近距离放射疗法来治疗局限性前列腺癌:一项描述性调查的结果
Urology. 2003 Feb;61(2):402-7. doi: 10.1016/s0090-4295(02)02162-3.
10
The patient's dilemma: prostate cancer treatment choices.患者的困境:前列腺癌的治疗选择
J Urol. 2003 Mar;169(3):828-33. doi: 10.1097/01.ju.0000052056.27609.8a.

局限性前列腺癌的治疗决策:年轻男性的选择及原因。

Treatment decision-making for localized prostate cancer: what younger men choose and why.

机构信息

Department of Urology, The Johns Hopkins Hospital, Baltimore, Maryland 21231, USA.

出版信息

Prostate. 2012 Jan;72(1):58-64. doi: 10.1002/pros.21406. Epub 2011 Apr 25.

DOI:10.1002/pros.21406
PMID:21520163
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4612632/
Abstract

BACKGROUND AND OBJECTIVE

The literature lacks knowledge about information preferences and decision-making in young prostate cancer patients. This study provides insight into information sources consulted and factors dictating treatment decision-making in young prostate cancer patients.

METHODS

Subjects were identified from pathology consult service of a National Center of Excellence. Questionnaires were mailed to 986 men, under 50 years of age, diagnosed with Gleason score 6 prostate cancer between 2001 and 2005.

RESULTS

Four hundred ninety-three men responded. The most common primary therapies were surgery 397 (81.4%), radiation 52 (10.7%), and active surveillance (AS) 26 (5.3%). Participants with at least some college education (P = 0.003) or annual income >$100,000 (P = 0.003) were more likely to consult three or more doctors. Amongst all treatments, "doctor's recommendation" was the most influential information source, although relatively less important in the AS group. Internet was the second most frequent information source. Participants with higher education (P = 0.0003) and higher income (P = 0.002) considered sexual function more important while making a treatment choice. Only 2% of the men preferred a passive role in the decision-making. Informed decision-making was preferred more by patients who chose radiation and AS while shared decision-making was preferred more by surgery patients (P < 0.05). The majority (89%) of the respondents did not regret their decision. No difference in satisfaction levels was found between different treatment modalities.

CONCLUSIONS

This study provides insight into information sources consulted, such as the greater internet use, and various factors dictating treatment decision-making in young prostate cancer patients. There was an overall very high satisfaction rate regardless of the therapy chosen.

摘要

背景与目的

目前文献中缺乏有关年轻前列腺癌患者信息偏好和决策的知识。本研究旨在深入了解年轻前列腺癌患者咨询的信息来源和影响治疗决策的因素。

方法

从国家卓越中心的病理咨询服务中确定研究对象。2001 年至 2005 年间,向 986 名年龄在 50 岁以下、诊断为 Gleason 评分 6 前列腺癌的男性邮寄问卷。

结果

493 名男性做出回应。最常见的主要治疗方法是手术 397 例(81.4%)、放疗 52 例(10.7%)和主动监测(AS)26 例(5.3%)。至少受过大学教育(P = 0.003)或年收入超过 100,000 美元(P = 0.003)的参与者更有可能咨询三位或更多医生。在所有治疗方法中,“医生的建议”是最有影响力的信息来源,尽管在 AS 组中相对不太重要。互联网是第二大常用信息来源。受教育程度较高(P = 0.0003)和收入较高(P = 0.002)的参与者在做出治疗选择时更看重性功能。只有 2%的男性在决策中更喜欢被动角色。选择放疗和 AS 的患者更倾向于知情决策,而选择手术的患者更倾向于共同决策(P < 0.05)。大多数(89%)患者对自己的决定不后悔。不同治疗方式之间的满意度水平没有差异。

结论

本研究深入了解了年轻前列腺癌患者咨询的信息来源,如更多地使用互联网,以及影响他们治疗决策的各种因素。无论选择哪种治疗方式,总体满意度都非常高。